AI Article Synopsis
- Poor adherence to acne medication leads to ineffective treatment plans, making it essential to identify and address the reasons behind nonadherence.
- The study analyzed 29 articles to pinpoint these hurdles, which include lack of knowledge, confusion, weak doctor-patient relationships, fear of side effects, and costs for those who don't even start treatment; as well as issues like complexity, lack of results, side effects, forgetfulness, and busy lifestyles for those who do start but don't stick to it.
- Potential solutions involve simplifying treatment, utilizing technology, and providing better education to help patients adhere to their acne medication effectively.
Article Abstract
Background: Adherence to acne medication is poor and is a major reason why treatment plans are ineffective. Recognizing solutions to nonadherence is critical.
Objective: The purpose of this study is to describe the hurdles associated with acne nonadherence and to provide mechanisms on how to ameliorate them.
Methods: PubMed database was searched. Of the 419 search results, 29 articles were reviewed to identify hurdles to adherence and corresponding solutions.
Results: Hurdles to primary nonadherence where the medication is not even started, include lack of knowledge, confusion about usage, weak physician-patient relationship, fear of adverse reactions, and cost. Secondary nonadherence hurdles where the medication is started but is not taken as directed include lack of results, complex regimens, side effects, busy lifestyle, forgetfulness, inconvenience, and psychiatric comorbidity. Solutions to these hurdles include treatment simplification, technology, and dynamic education.
Limitations: Adherence is affected by numerous factors, but available literature analyzing acne adherence and interventions to improve adherence to treatment is limited.
Conclusion: There are several hurdles in adhering to acne treatment. Recognition of these hurdles and finding appropriate solutions may be as important to treatment outcomes as choosing the right medication to prescribe.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067002 | PMC |
| http://dx.doi.org/10.2147/PPA.S117437 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Therapeutic potential of 3-acetyl coumarin against polycystic ovarian syndrome induced by letrozole using female rats.
Naunyn Schmiedebergs Arch Pharmacol
December 2024
Laboratory of Biotechnology and Natural Resources Valorization, Faculty of Sciences, Ibn Zohr University, 80060, Agadir, Morocco.
Polycystic ovarian syndrome is a heterogeneous endocrine disorder characterized by ovarian cysts, anovulation, endocrine variations, which includes oligo-amenorrhea along with associated subfertility and hyperandrogenism manifested as acne, hirsutism, and male-pattern alopecia. Coumarins are fused benzene and pyrone ring systems that exhibit a wide spectrum of bioactivities. This study aimed to investigate the effects of 3-acetyl coumarin (3-AC) on polycystic ovarian syndrome in female rats.
View Article and Find Full Text PDFHydrogel-Forming Microneedles in the Management of Dermal Disorders Through a Non-Invasive Process: A Review.
Gels
November 2024
Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
Article Synopsis
- Microneedle (MN) technology, particularly hydrogel-forming microneedles (HFMNs), offers an innovative non-invasive method for delivering drugs through the skin, promising significant improvements in treating various dermatological conditions like acne and psoriasis.!* -
- HFMNs are composed of small needles made from hydrophilic polymers that can penetrate the skin’s outer layer without harming underlying tissues; they absorb fluid to form a hydrogel that aids in transporting therapeutic agents directly into the dermal microcirculation.!* -
- The technology is designed to reduce patient discomfort compared to traditional needles, enabling better drug delivery with controlled release profiles, and it also allows for real-time monitoring of interstitial fluid, enhancing the
One Acne™: a holistic management approach to improve overall skin quality and treatment outcomes in acne with or without sensitive skin.
Int J Dermatol
November 2024
Skin Research Centre, University of York, York, UK.
Acne and sensitive skin can take a profound toll on patients' well-being, which can be exacerbated if the conditions are experienced together. This narrative review aims to identify appropriate treatments to facilitate a holistic management approach to acne (One Acne™), sensitive skin, and acne-induced sequelae and describe the role of treatments in improving skin quality. Topical retinoids are considered the preferred first-line option for acne treatment by dermatologists, either as monotherapy or in combination with other treatments, because of their ability to target various aspects of the disease.
View Article and Find Full Text PDFThe dietary phytochemical index and its relation to polycystic ovary syndrome: a case-control study.
J Ovarian Res
November 2024
Department of Gynaecology, The Second People's Hospital of Liaocheng, Liaocheng, Shandong, 262600, China.
Background: Polycystic ovary syndrome (PCOS), a hormonal disorder affecting women of reproductive age, can be significantly impacted by diet. This study explores the relationship between a diet rich in phytochemicals, measured by the Dietary Phytochemical Index (DPI), and PCOS, along with associated health markers.
Methods: A case-control study design was implemented with 480 individuals diagnosed with PCOS based on the Rotterdam criteria, paired with 480 controls matched in terms of age and BMI.
Innovations in Acne.
Dermatol Clin
January 2025
Department of Dermatology, Brigham and Women's Hospital, 41 Avenue Louis Pasteur, 317A, Boston, MA 02115, USA. Electronic address:
Although many treatments are available for acne, these can be limited by lack of effectiveness, patient tolerance and adherence, and accessibility. This review provides a comprehensive summary of the latest developments in acne management, exploring a range of topical, systemic, and procedural treatments. The mechanisms of action, pivotal trial data, and potential role in clinical practice are reviewed for emerging therapies such as 1726 nm laser, sarecycline, clascoterone, trifarotene, minocycline foam, and fixed-dose combination topicals.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!